Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market 2028 By Product, Application, End-User | The Insight Partners

report image

Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Consumables and Accessories, Services, Software); Application (Cancer Diagnosis, Genetic Disease Diagnosis, Others); End-User (Diagnostic Laboratories, Research and Academic Institutes, Others)

Report Code: TIPHE100001252 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Fluorescence in situ hybridization (FISH) is a cytogenetic method that practices fluorescent probes of the chromosome to represent a high degree of sequence complementarity. Fluorescence microscopy is used to discover where the fluorescent probe is bound to the chromosome. This technique gives an innovative approach for researchers to visualize and outline the genetic material in a single cell, including particular genes or portions of genes. FISH an essential tool for understanding a diversity of chromosomal abnormalities and other genetic mutations.


The "Global Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the fluorescence in-situ hybridization (FISH) imaging systems market with detailed market segmentation by product, application, end user, and geography. The report provides key statistics on the market status of the leading fluorescence in-situ hybridization (FISH) imaging systems market players and offers key trends and opportunities in the market.


  •   Based on product, the global fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables and accessories, services, software.
  •   Based on application, the global fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, others.
  •   Based on end user, the market is segmented into diagnostic laboratories, research and academic institutes, others.



  •   Rising demand for the diagnostics for the detecting the infectious diseases
  •   Increasing prevalence of genetic diseases and cancer
  •   Technological advancements and increasing automation by several companies.


  •   High Cost of fluorescence in-situ hybridization (FISH) imaging systems


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The fluorescence in-situ hybridization (FISH) imaging systems market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the fluorescence in-situ hybridization (FISH) imaging systems market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the fluorescence in-situ hybridization (FISH) imaging systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The impact of SARS-CoV-2 has changed across nations with alternating cardiovascular indications. The market payers from fluorescence in-situ hybridization (FISH) imaging systems market are anticipated to lucrative growth opportunities in the future with the rising demand for fluorescence in-situ hybridization (FISH) imaging systems in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the fluorescence in-situ hybridization (FISH) imaging systems market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   MetaSystems
  •   PerkinElmer, Inc.
  •   Leica Biosystems
  •   Bio-Rad Laboratories, Inc.
  •   BioTek Instruments, Inc.
  •   GE Healthcare
  •   Thermo Fisher Scientific, Inc.
  •   TissueGnostics GmbH
  •   Applied Spectral Imaging

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

2. MetaSystems
3. PerkinElmer, Inc.
4. Leica Biosystems
5. Bio-Rad Laboratories, Inc.
6. BioTek Instruments, Inc.
7. GE Healthcare
8. Thermo Fisher Scientific, Inc.
9. TissueGnostics GmbH
10. Applied Spectral Imaging
12. Abnova Corporation
13. Biodot Inc.
14. Genemed Technologies, Inc.
15. Merck KGaA
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount